Work

Phase 1b study of abiraterone acetate (AA) and docetaxel (D) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.5025

Authors: Scott T. Tagawa, Edwin M. Posadas, Justine Yang Bruce, Emerson A. Lim, Daniel Peter Petrylak, Weimin Peng, Raymond Scott Maul, Hans W. Smit, Namphuong Tran, David M. Nanus

Institutions: Weill Cornell Medicine, Cedars-Sinai Medical Center, University of Wisconsin–Madison, Columbia University Irving Medical Center, Yale Cancer Center, Janssen (Belgium)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2908141906

Cites:

Cited by: 2

Related to: 10